Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication
Mike He, Jane Lovell, Bee Ling Ng, John Spillane, David Speakman, Michael A Henderson, Mark Shackleton, David E Gyorki
Journal of Surgical Oncology | WILEY-BLACKWELL | Published : 2015
The authors thank Ann Fennessy for assistance in identifying patients for the study. Mark Shackleton was supported by the Australian National Health and Medical Research Council, Pfizer Australia and the Victorian Endowment for Science, Knowledge and Innovation.